Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Here, we successfully induced the in vitro formation of Toxoplasma cysts-like structures from tachyzoites of the type I RH strain by treating with mycophenolic acid , an inhibitor of the inosine monophosphate dehydrogenase.”
“ MPA exerts its immunosuppression by inhibiting inosine 5'-monophosphate dehydrogenase (IMPDH), depleting activated lymphocytes of guanine nucleotides and retarding their proliferation.”
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2015 | View Paper
“Mycophenolic acid MPA ) is a selective inhibitor of inosine 5′-monophosphate dehydrogenase (IMPDH), the rate-limiting enzyme of de novo synthesis of guanine nucleotides.”
“ Mycophenolic acid , the active metabolite of MMF, selectively inhibits inosine 5’-monophosphate dehydrogenase, a key enzyme of the purine de novo synthesis pathway of guanosine nucleotides [1].”
“ MPA , a fermentation product of Penicillium brevicompactum and related fungi, is an inhibitor of inosine monophosphate dehydrogenase, a key enzyme in the de novo pathway of purine synthesis.”
Clinical journal of the American Society of Nephrology : CJASN • 2007 | View Paper
“BACKGROUND The mechanism of action of mycophenolic acid (MPA) has been described as a blockade of inosine 5'-monophosphate dehydrogenase (IMPDH) and is thought to selectively influence T- and B-lymphocytes due to their strong dependency on guanine nucleotides synthesized via the de novo purine synthesis pathway.”